AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (September 26, 2007). doi:10.1152/ajpregu.00911.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/6/R2163    most recent
00911.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Alessio, D.
Right arrow Articles by Tso, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Alessio, D.
Right arrow Articles by Tso, P.
Submitted on December 29, 2006
Accepted on September 20, 2007

Fasting and postprandial concentrations of glucagon-like peptide 1 in intestinal lymph and portal plasma: Evidence for selective release of GLP-1 into the lymph system

David D'Alessio1*, Wendell J. Lu2, William Sun3, Shuqin Zheng3, Qing Yang3, Randy Seeley4, Stephen C Woods4, and Patrick Tso3

1 Division of Endocrinology & Metabolism, University of Cincinnati College of Medicine, Cincinnati,, Ohio, United States
2 Physiology, University of Cincinnati, Cincinnati, Ohio, United States
3 Pathology, University of Cincinnati, Cincinnati, Ohio, United States
4 Psychiatry, University of Cincinnati, Cincinnati, Ohio, United States

* To whom correspondence should be addressed. E-mail: dalessd{at}ucmail.uc.edu.

Glucagon like peptide 1, an intestinal hormone that plays an important role in glucose metabolism, is released from mucosal L-cells following nutrient ingestion and contributes to the incretin effect (enhancement of insulin secretion resulting from enteral versus intravenous glucose administration). Mechanisms linking nutrient absorption and GLP-1 secretion are unknown; studies addressing this have been hampered by relatively low concentrations of GLP-1 in the circulation, particularly in small animal models. We hypothesized that GLP-1 levels are higher in intestinal lymph than plasma, and provide a novel system in which to study meal-induced hormone secretion. We addressed this hypothesis in conscious rats with indwelling portal vein and distal intestinal lymph duct catheters. Plasma and lymph were sampled before and for 240 minutes after instillation of a liquid meal into the gastrointestinal tract. Lymph concentrations of glucose, insulin, and GLP-1 were assayed. Before and after the Ensure feeding, portal plasma insulin levels were approximately twice those found in intestinal lymph. Contrastingly, GLP-1 levels were 5-6 times higher in lymph than portal plasma following nutrient administration (and even higher compared to peripheral circulation), and these levels dramatically exceeded the ratio of lymph:plasma PYY concentrations. This is the first observation of a GI hormone being disproportionately transported into lymph. Remarkable levels of GLP-1 in intestinal lymph suggest lymphatic sampling as a more sensitive means of studying GLP-1 secretion in vivo. Additionally, the possibility is raised that intestinal lymph may serve as a specialized signaling conduit for regulatory peptides secreted by GI endocrine cells.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso
Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose
Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1130 - G1138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. M. S. Johnson, D. S. Edgerton, T. Rodewald, M. Scott, B. Farmer, D. Neal, and A. D. Cherrington
Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E380 - E384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.